Blasenkarzinom: Neue Perspektiven in der Behandlung (German Edition)
Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer. Prostate cancer in the elderly. Circulating prostate tumor cells detected by reverse transcription-PCR in men with localized or castration-refractory prostate cancer: Edward Friedman's Letter to the Editor re: Hendrik Isbarn, Jehonathan H. Testosterone and Prostate Cancer: Prevalence of a tertiary Gleason grade and its impact on adverse histopathologic parameters in a contemporary radical prostatectomy series.
Reply from Authors re: Evangelos Liatsikos, Panagiotis Kallidonis. Laparoscopic or Open Nephroureterectomy? Which is the More Efficient Way to go? Effect of body mass index on histopathologic parameters: Thirty-day mortality after transurethral resection of the prostate in patients treated with androgen deprivation therapy. Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma.
A population based assessment of perioperative mortality after cystectomy for bladder cancer. Predicting cancer-control outcomes in patients with renal cell carcinoma. Improved risk stratification for prostate cancer. Differences in histopathological and biochemical outcomes in patients with low Gleason score prostate cancer.
Residual pathological stage at radical cystectomy significantly impacts outcomes for initial T2N0 bladder cancer. Unilateral prostate cancer cannot be accurately predicted in low-risk patients. External validation of a preoperative nomogram for prediction of the risk of recurrence after radical prostatectomy. Long-term data on the survival of patients with prostate cancer treated with radical prostatectomy in the prostate-specific antigen era. A population-based analysis of the rate of cytoreductive nephrectomy for metastatic renal cell carcinoma in the United States.
Development and external validation of a highly accurate nomogram for the prediction of perioperative mortality after transurethral resection of the prostate for benign prostatic hyperplasia. Survival after radical prostatectomy and radiotherapy for prostate cancer: A population-based assessment of perioperative mortality after nephroureterectomy for upper-tract urothelial carcinoma. Conditional survival predictions after nephrectomy for renal cell carcinoma. Persistent genital arousal disorder: Persistent genital arousal disorder PGAD: Head-to-head comparison of the three most commonly used preoperative models for prediction of biochemical recurrence after radical prostatectomy.
Prognostic significance of lymph node invasion in patients with metastatic renal cell carcinoma: Tumor size is a determinant of the rate of stage T1 renal cell cancer synchronous metastasis. Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: Temporal stage and grade migration in surgically treated patients with upper tract urothelial carcinoma. The European Network for the Study of Adrenal Tumors staging system is prognostically superior to the international union against cancer-staging system: A North American validation.
Safety and efficacy of vardenafil versus sertraline in the treatment of premature ejaculation: Eine Disziplin in der Entwicklung. Downsides of robot-assisted laparoscopic radical prostatectomy: Interobserver variation in grading and staging of squamous cell carcinoma of the penis in relation to the clinical outcome. Lymphatic spread in squamous cell carcinoma of the penis is independent of elevated lymph vessel density. Adjuvant radiotherapy after radical prostatectomy shows no ability to improve rates of overall and cancer-specific survival in a matched case-control study.
Surgery illustrated--focus on details: ERG fusion transcripts in urine from prostate cancer patients correlate with a less favorable prognosis. The feasibility of prostate cancer detection by triple spectroscopy. Importance of baseline potency rate assessment of men diagnosed with clinically localized prostate cancer prior to radical prostatectomy. Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.
Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomy. Survivin as a prognostic marker for urothelial carcinoma of the bladder: Preliminary results from a prospective histology-based study. A delay in radical nephroureterectomy can lead to upstaging. Risk-adjusted hazard rates of biochemical recurrence for prostate cancer patients after radical prostatectomy.
Nomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancer. External validation of a nomogram predicting mortality in patients with adrenocortical carcinoma. A simple and accurate model for prediction of cancer-specific mortality in patients treated with surgery for primary penile squamous cell carcinoma. Prostate cancer detection rate in patients with repeated extended sample needle biopsy.
Lymphovascular invasion and pathologic tumor stage are significant outcome predictors for patients with upper tract urothelial carcinoma. Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer. Is node-positive prostate cancer always a systemic disease? A nomogram is more accurate than a regression tree in predicting lymph node invasion in prostate cancer. Acute abdomen caused by endometrial stromal sarcoma arising in extragonadal foci of endometriosis of the terminal ileum.
Assessment of biochemical recurrence rate in patients with pathologically confirmed insignificant prostate cancer. Prostate cancer characteristics in a multiracial community. Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men. Assessment of pathological prostate cancer characteristics in men with favorable biopsy features on predominantly sextant biopsy.
Sequential use of the tyrosine kinase inhibitors sorafenib and sunitinib in metastatic renal cell carcinoma: Sorafenib for older patients with renal cell carcinoma: Prevalence of human gammaretrovirus XMRV in sporadic prostate cancer.
Dr. Zhantong Mao has not added a biography.
Distinct subcellular expression patterns of neutral endopeptidase CD10 in prostate cancer predict diverging clinical courses in surgically treated patients. Evaluation of cytotoxic effects induced by bcl-2 and bcl-xL antisense-oligodeoxynucleotides in normal urothelium and transitional cell carcinoma. Comparison of stage migration patterns between Europe and the USA: Mortality at days after prostatic biopsy: Epidemiological survey of families with bladder exstrophy-epispadias complex.
Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy. Urinary cytology and nuclear matrix protein 22 in the detection of bladder cancer recurrence other than transitional cell carcinoma.
ERG fusion transcripts in urine from prostate cancer patients correlate with a less favorable prognosis. A gene model for molecular nodal staging of bladder cancer: CEA-related cell adhesion molecule-1 is involved in angiogenic switch in prostate cancer. Kernspinangiographische Darstellung der experimentellen Lungenarterienembolie mit Hilfe eines makromolekularen Kontrastmittels. Conditional survival of patients with urothelial carcinoma of the urinary bladder treated with radical cystectomy. For the new edition a further chapter has been added, and almost half of the chapters have been extensively revised and the others updated. Miliary never-smoking adenocarcinoma of the lung:
Consider Both Benefits and Risks. High surgical volume is associated with a lower rate of secondary therapy after radical prostatectomy for localized prostate cancer. High provider volume is associated with lower rate of secondary therapies after definitive radiotherapy for localized prostate cancer. Validation of the contemporary epstein criteria for insignificant prostate cancer in European men.
Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: The effect of comorbidity and socioeconomic status on sexual and urinary function and on general health-related quality of life in men treated with radical prostatectomy for localized prostate cancer. Biopsies performed at tertiary care centers are superior to referral biopsies in predicting pathologic Gleason sum. Expression and prognostic relevance of annexin A3 in prostate cancer. Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than grams: Surgical anatomy of the frontal recess--is there a benefit in multiplanar CT-reconstruction?
Long-term treatment of erectile dysfunction with a phosphodiesterase-5 inhibitor and dose optimization based on nocturnal penile tumescence. Review of the literature: Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Penile implantation in Europe: Currently used criteria for active surveillance in men with low-risk prostate cancer: A nomogram predicting long-term biochemical recurrence after radical prostatectomy.
Evaluation of prostate cancer detection with ultrasound real-time elastography: Molecular cancer phenotype in normal prostate tissue.
Publikationen
Clinical significance of p53 alterations in surgically treated prostate cancers. Marked gene transcript level alterations occur early during radical prostatectomy. Microsatellite analysis of allelic imbalance in tumour and blood from patients with prostate cancer. Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkers. Early postoperative plasma transforming growth factor-beta1 is a strong predictor of biochemical progression after radical prostatectomy.
External validation of a biomarker-based preoperative nomogram predicts biochemical recurrence after radical prostatectomy. Serum markers for prostate cancer: The effect of surgical volume, age and comorbidities on day mortality after radical prostatectomy: Lower urinary tract symptoms affect one-third of men in a prostate cancer screening population. Accuracy of life tables in predicting overall survival in patients after radical prostatectomy. Baseline prevalence of erectile dysfunction in a prostate cancer screening population. Adjuvant chemotherapy for bladder cancer does not alter cancer-specific survival after cystectomy in a matched case-control study.
Positive Surgical Margins in Radical Prostatectomy: Comparable efficacy of once-daily versus on-demand vardenafil in men with mild-to-moderate erectile dysfunction: Inhibition of dendritic cell generation and function by serum from prostate cancer patients: Holmium laser enucleation versus transurethral resection of the prostate: Optimizing chemotherapy for transitional cell carcinoma by application of bcl-2 and bcl-xL antisense oligodeoxynucleotides.
Systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy. Critical assessment of ideal nodal yield at pelvic lymphadenectomy to accurately diagnose prostate cancer nodal metastasis in patients undergoing radical retropubic prostatectomy.
A nomogram for staging of exclusive nonobturator lymph node metastases in men with localized prostate cancer. Prostate volume and adverse prostate cancer features: Preserved postoperative penile size correlates well with maintained erectile function after bilateral nerve-sparing radical retropubic prostatectomy. Percentage of positive biopsy cores can improve the ability to predict lymph node invasion in patients undergoing radical prostatectomy and extended pelvic lymph node dissection.
Management of erectile dysfunction after radical prostatectomy in Differences in the rate of lymph node invasion in men with clinically localized prostate cancer might be related to the continent of origin. Treatment of localized prostate cancer. Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium.
Body mass index does not improve the ability to predict biochemical recurrence after radical prostatectomy. Development and external validation of an extended core biopsy nomogram. Development and external validation of an extended repeat biopsy nomogram. Zonal origin of localized prostate cancer does not affect the rate of biochemical recurrence after radical prostatectomy. Tumour volume and high grade tumour volume are the best predictors of pathologic stage and biochemical recurrence after radical prostatectomy. Initial biopsy outcome prediction--head-to-head comparison of a logistic regression-based nomogram versus artificial neural network.
Distribution of prostate specific antigen PSA and percentage free PSA in a contemporary screening cohort with no evidence of prostate cancer. A critical appraisal of logistic regression-based nomograms, artificial neural networks, classification and regression-tree models, look-up tables and risk-group stratification models for prostate cancer. Role of nomograms for prostate cancer in Screening men for prostate cancer and colorectal cancer: Nerve distribution along the prostatic capsule.
Sigma-rectum pouch Mainz pouch II. Effect of autologous blood transfusion on the rate of biochemical recurrence after radical prostatectomy. Development and split-sample validation of a nomogram predicting the probability of seminal vesicle invasion at radical prostatectomy.
Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancer. Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men.
Is the open retropubic radical prostatectomy dead? Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening. Prospective non-randomized evaluation of four mediators of the systemic response after extraperitoneal laparoscopic and open retropubic radical prostatectomy.
Multi-institutional validation of a new renal cancer-specific survival nomogram. Patients responding to phosphodiesterase type 5 inhibitor therapy: Plasma tissue factor antigen in localized prostate cancer: Interleukin-2 inhalation therapy temporarily induces asthma-like airway inflammation. High accuracy of virtual simulation with the laser system Dorado CT4. Do bladder cancer patients with metastatic spinal cord compression benefit from radiotherapy alone? Molecular staging of prostate cancer in the year Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer.
Detection of tumor-specific DNA in blood and bone marrow plasma from patients with prostate cancer. Therapy of recurrent disease after radical prostatectomy in Improved spontaneous erectile function in men with mild-to-moderate arteriogenic erectile dysfunction treated with a nightly dose of sildenafil for one year: Circulating biomarkers for prostate cancer. Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy.
Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer. Colon pouch Mainz III for continent urinary diversion. Accuracy of life tables in predicting overall survival in candidates for radiotherapy for prostate cancer.
Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer.
A nomogram predicting year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer. Basic principles of anatomy for optimal surgical treatment of prostate cancer. Ejaculatory disorders may affect screening for prostate cancer. Impact of chronic prostatitis-like symptoms on the quality of life in a large group of men. External validation of a nomogram for prediction of side-specific extracapsular extension at robotic radical prostatectomy.
Surgical volume is related to the rate of positive surgical margins at radical prostatectomy in European patients. The AJCC pT2 substages confer no prognostic information on the rate of biochemical recurrence after radical prostatectomy. Significant upgrading affects a third of men diagnosed with prostate cancer: Anatomic radical retropubic prostatectomy-long-term recurrence-free survival rates for localized prostate cancer.
Circulating tumour-associated plasma DNA represents an independent and informative predictor of prostate cancer. Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology. Frozen section for the management of intraoperatively detected palpable tumor lesions during nerve-sparing scheduled radical prostatectomy. Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder.
Prediction of postoperative sexual function after nerve sparing radical retropubic prostatectomy. Enhanced discrimination of benign from malignant prostatic disease by selective measurements of cleaved forms of urokinase receptor in serum. Variability in the performance of nuclear matrix protein 22 for the detection of bladder cancer. Evaluation of tetrahydrobiopterin BH4 as a potential therapeutic agent to treat erectile dysfunction. Development and internal validation of preoperative transition zone prostate cancer nomogram.
Adolescent smoking and depression: Comparative assessment of the and pathologic T3 substages for the prediction of biochemical recurrence after radical prostatectomy. Validation of a nomogram for prediction of side specific extracapsular extension at radical prostatectomy. Risk assessment for biochemical recurrence prior to radical prostatectomy: CEA-related cell adhesion molecule-1 is involved in angiogenic switch in prostate cancer. High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series. Prognostic relevance of methylation markers in patients with non-muscle invasive bladder carcinoma.
Reasonable delay of surgical treatment in men with localized prostate cancer--impact on prognosis? Comparison of predictive accuracy for pathologically organ confined clinical stage T1c prostate cancer using human glandular kallikrein 2 and prostate specific antigen combined with clinical stage and Gleason grade. Stage-dependent increase of orosomucoid and zinc-alpha2-glycoprotein in urinary bladder cancer.
A multicenter clinical trial on the use of -5, -7 pro prostate specific antigen. Detection of human telomerase RNA in the tumour-surrounding mucosa of bladder carcinomas as a marker for premalignant transformation. Surgical management of prostate cancer: Influence of nerve-sparing NS procedure during radical prostatectomy RP on margin status and biochemical failure.
Extraction and processing of high quality RNA from impalpable and macroscopically invisible prostate cancer for microarray gene expression analysis. Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder. Transition zone cancers undermine the predictive accuracy of Partin table stage predictions.
Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue. Low-latitude seasonality of Cretaceous temperatures in warm and cold episodes. Expression of Maspin in non-muscle invasive bladder carcinoma: Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients.
Assessment of the enhancement in predictive accuracy provided by systematic biopsy in predicting outcome for clinically localized prostate cancer. Prostate-specific antigen and related isoforms in the diagnosis and management of prostate cancer. Extracorporeal shockwave lithotripsy compared with ureteroscopy for the removal of small distal ureteral stones. Immunocyt and the HA-HAase urine tests for the detection of bladder cancer: Dual role of carcinoembryonic antigen-related cell adhesion molecule 1 in angiogenesis and invasion of human urinary bladder cancer.
A side by side comparison of cytology and biomarkers for bladder cancer detection. Myeloid sarcoma of the prostate as first clinical manifestation of acute myeloid leukaemia. Comparison of the ImmunoCyt test and urinary cytology with other urine tests in the detection and surveillance of bladder cancer. Differences in biopsy features between prostate cancers located in the transition and peripheral zone. Are false-positive urine markers for the detection of bladder carcinoma really wrong or do they predict tumor recurrence?
Comparison of multitarget fluorescence in situ hybridization in urine with other noninvasive tests for detecting bladder cancer. Can predictive models for prostate cancer patients derived in the United States of America be utilized in European patients? A validation study of the Partin tables. Quantitative biopsy pathology for the prediction of pathologically organ-confined prostate carcinoma: The role of human glandular kallikrein 2 for prediction of pathologically organ confined prostate cancer.
Total, free and complexed PSA and hK2 for early detection of prostate cancer. Standardization of two immunoassays for human glandular kallikrein 2. Evaluation of renal growth by magnetic resonance imaging and computerized tomography volumes. Analysis of clinical stage T2 prostate cancer: Clinical use of urinary markers for the detection and prognosis of bladder carcinoma: Fault mechanics and transport properties of rocks: Brace by Brian Evans 20 editions published between and in English and held by WorldCat member libraries worldwide This festschrift, compiled from the symposium held in honor of W.
Brace, is a timely overview of fault mechanics and transport properties of rock. State-of-the-art research is presented by internationally recognized experts, who highlight developments in this contemporary area of study subsequent to Bill Brace's pioneering work.
Post-failure behavior of westerly granite at elevated temperatures by Teng-fong Wong 2 editions published in in English and held by 3 WorldCat member libraries worldwide. Strength recovery in rocks and minerals: Permeability and strength of core samples from the Taiwan Chelungpu-fault drilling project: The physics and mechanics of the brittle-ductile transition: Cyclic stick-slip instability as related to the earthquake cycle by Teng-fong Wong Book 1 edition published in in English and held by 2 WorldCat member libraries worldwide.
Jikken ganseki rikigaku 1 edition published in in English and held by 1 WorldCat member library worldwide The primary aim of this monograph is to present the current knowledge of brittle properties of rocks as determined in laboratory experiments. Wie sicher sind wir uns? Woher beziehen wir unser Wissen? Diese Informationsseiten sind nach wissenschaftlichen Kriterien aufbereitet und zusammengestellt. Biologische und pharmakologische Wirkungen von Viscum album L. Verschiedene pharmakologisch aktive Bestandteile wurden isoliert, wie z.
Kohortenstudien ; oder es werden die Mistelextrakte standardisiert verabreicht, z. Weiteres siehe Standardisierung — Dosierung.
Die klinische Wirksamkeit der Mistel wird kontrovers diskutiert. Weiteres siehe Klinische Studien. Fortschritte in der Misteltherapie. Aktueller Stand der Forschung und klinischen Anwendung. Schweizer, Viscum album L. Eur J Cancer 30A, Schweizer, Suppression of sister chromatid exchange-including DNA lesions in cultured peripheral blood mononuclear cells by Viscum album L.
J Exp Clin Cancer Res 15, Schweizer, Effects of Viscum album L. Cancer Lett Anticancer Res 18, Schweizer, Induction of apoptosis in human lymphocytes treated with Viscum album L.